Anais Brasileiros de Dermatologia

ISSN: 0365-0596

Anais Brasileiros de Dermatologia is the official scientific publication of the Brazilian Society of Dermatology (SBD - Sociedade Brasileira de Dermatologia). The journal has been published since 1925.

It is a bimonthly open access peer-reviewed journal devoted to the dissemination of studies, evidence and technical-scientific reports that are original and unpublished, results from research, reviews or communications about dermatology and related fields.

The journal is focused on Tropical Dermatology, Parasitic and Infectious Dermatology, STDs/AIDS and Dermopathology.

The opinions and statements contained in the journal are the sole and exclusive responsibility of their authors, and do not necessarily coincide with those of the Editorial Staff, the Advisory Board or the Brazilian Society of Dermatology.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.4

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.43

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.90

View more metrics

Open Access Option

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original Article

Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study

Anete S. Grumacha,

Corresponding author

anete.grumach@fmabc.net

Corresponding author.

, Marina T. Henriquesa, Maine L.D. Bardoua, Daniele A. Pontarollia, Jaco Bothab, Mariangela Correac, for the IOS Brazil Study Group

a Clinical Immunology, Faculdade de Medicina, Centro Universitario Saúde ABC, Santo André, SP, Brazil

b Takeda Pharmaceuticals International AG, Zurich, Switzerland

c Takeda Distribuidora Ltda, São Paulo, SP, Brazil

Read

21727

Times
was read the article

3118

Total PDF

18609

Total HTML

Share statistics

Article information

ISSN: 03650596
Original language: English

DOI:10.1016/j.abd.2021.09.009

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	57	18	75
2025 5	288	70	358
2025 4	250	103	353
2025 3	265	87	352
2025 2	654	89	743
2025 1	305	73	378
2024 12	140	60	200
2024 11	198	77	275
2024 10	229	94	323
2024 9	276	102	378
2024 8	298	122	420
2024 7	266	135	401
2024 6	241	122	363
2024 5	166	74	240
2024 4	218	103	321
2024 3	180	89	269
2024 2	191	98	289
2024 1	127	66	193
2023 12	157	76	233
2023 11	209	125	334
2023 10	203	92	295
2023 9	169	116	285
2023 8	174	50	224
2023 7	179	54	233
2023 6	9235	94	9329
2023 5	164	55	219
2023 4	176	39	215
2023 3	206	83	289
2023 2	136	52	188
2023 1	121	54	175
2022 12	200	54	254
2022 11	201	97	298
2022 10	294	141	435
2022 9	199	104	303
2022 8	516	71	587
2022 7	996	91	1087
2022 6	725	88	813

Show all

Follow this link to access the full text of the article

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter